Have any questions?
+44 1234 567 890
Integrated Working Group "Cell Therapy"
Researchers, clinicians and students from various MHB locations form this multidisciplinary team, in collaboration with external partners. The thematic emphasis is on preclinical and translational research in the field of cellular oncological immunotherapy, with a focus on DFG-funded projects concerning NK cell and T cell therapy.
The working group aims to develop innovative and patient-oriented treatment concepts and implement them in clinical practice. The range of topics addressed fits in with the MHB focus on oncological disorders and the research focus at the Faculty of Health Sciences on medicine and health in the care of aging and geriatric patients.
Further external partners:
-
Hans Hofmeister (CEO, Zellwerk GmbH)
-
Evgenueni Sinelnikov (Zellwerk GmbH)
For more detailed information (in German) see here.